T he genetic basis for essential hypertension has been difficult to decipher. Considering that the intricate control of blood pressure (BP) is governed by a myriad of anatomic, physiological, and biochemical systems, multiple genes are likely to influence an individual's BP and susceptibility to develop hypertension. The impact of any single gene may not overtly manifest because its effects may be reduced and diluted as these are transmitted across many layers of biological control. However, a gene whose product affects the function or expression of several other genes would conceivably have a greater combined effect on BP and thus, would be an attractive target in the study of new approaches to the management of hypertension. The G-protein-coupled receptor kinase type 4 (GRK4) is one such gene. It plays a critical role in the activity of the peripheral dopaminergic system by phosphorylating and desensitizing the renal dopamine D 1 and D 3 receptors (D 1 R and D 3 R, respectively). 1, 2 These receptors promote natriuresis, to keep BP in the normal range. 1, 3 The members of the GRK family are divided into 3 subfamilies: GRK1 and GRK7 belong to the rhodopsin kinase subfamily; GRK2 and GRK3 belong to the β-adrenergic receptor kinase subfamily; and GRK4, GRK5, and GRK6 belong to the GRK4 subfamily. The expression of GRK4 is limited to only a few organs, such as the brain 4 and kidney, 1, 3 which are important in the regulation of BP. [5] [6] [7] [8] The human GRK4 gene has at least 4 splice variants, 4, 9 denoted as GRK4α (longest form), GRK4β (no exon 2), GRK4γ (no exon 15), and GRK4δ (no exons 2 and 15). The GRK4γ isoform desensitizes the D 1 R and D 3 R.
1,2 The GRK4 gene, whose locus at 4p16.3 is linked to hypertension, 10 has several nonsynonymous gene variants that are associated Abstract-The influence of a single gene on the pathogenesis of essential hypertension may be difficult to ascertain, unless the gene interacts with other genes that are germane to blood pressure regulation. G-protein-coupled receptor kinase type 4 (GRK4) is one such gene. We have reported that the expression of its variant hGRK4γ 142V in mice results in hypertension because of impaired dopamine D 1 receptor. Signaling through dopamine D 1 receptor and angiotensin II type I receptor (AT 1 R) reciprocally modulates renal sodium excretion and blood pressure. Here, we demonstrate the ability of the hGRK4γ
142V to increase the expression and activity of the AT 1 R. We show that hGRK4γ 142V phosphorylates histone deacetylase type 1 and promotes its nuclear export to the cytoplasm, resulting in increased AT 1 R expression and greater pressor response to angiotensin II. AT 1 R blockade and the deletion of the Agtr1a gene normalize the hypertension in hGRK4γ 142V mice. These findings illustrate the unique role of GRK4 by targeting receptors with opposite physiological activity for the same goal of maintaining blood pressure homeostasis, and thus making the GRK4 a relevant therapeutic target to control blood pressure. with hypertension in several ethnic groups. [11] [12] [13] [14] These variants increase the serine phosphorylation of the dopamine receptors and uncouple them from their G proteins, 1 rendering them dysfunctional. The D 1 R-/G-protein uncoupling in hypertension is kidney-restricted, nephron segment-specific, and receptor-specific, and cosegregates with the hypertension in the spontaneously hypertensive rat. 1 Mice harboring the human hGRK4γ 142V variant (missense A142V; rs1024323) transgene develop hypertension, 1 demonstrating for the first time the causal role of a gene variant in hypertension. Variants of 4 other genes have to date been demonstrated to cause hypertension when heterologously expressed in mice, namely, AGT 15 that encodes angiotensinogen, AGTR1
16 that encodes the angiotensin II (Ang II) type 1 receptor (AT 1 R), CYP11B2 that encodes aldosterone synthase, 17 and UMOD 18 that encodes uromodulin. The hypertension in hGRK4γ 142V transgenic mice has been ascribed to the impairment of D 1 R. 1 However, studies in spontaneously hypertensive rats, normotensive Wistar Kyoto rats, old rats, and salt-sensitive mice suggest that renal GRK4 and AT 1 R interaction may be crucial to the overall regulation of sodium balance and BP. [19] [20] [21] The AT 1 R is activated by Ang II to promote vasoconstriction, antinatriuresis, and sympathetic nervous activation, resulting in increased BP. [5] [6] [7] This study tested the hypothesis that the hypertension in hGRK4γ 142V transgenic mice is caused, in part, by increased AT 1 R expression and activity, and highlights the critical role of GRK4 as an upstream regulator of both D 1 R and AT 1 R in the control of renal sodium excretion and BP.
Materials and Methods
Details are available in the online-only Data Supplement.
Cell Culture and Transfection
HEK-293 cells (ATCC and CRL-1573) were transfected with vectors expressing hGRK4γ WT or hGRK4γ 142V using TransIT-293 under zeocin selection. Mycoplasma-negative human renal proximal tubule cells (hRPTCs) from a normotensive white male 1 were grown in 12-well plates for transient transfection using Fugene 6.
Nuclear Expression of hGRK4γ
HEK-293 cells, stably transfected with hGRK4γ WT or hGRK4γ
142V
, and hRPTCs were grown on BioCoat coverslips (BD Bioscience), immunostained for GRK4 and AT 1 R, and counterstained with 4′,6-diamidino-2-phenylindole to visualize the nuclei. Nuclear and cytosolic fractions from hRPTCs and HEK-293 cells stably transfected with hGRK4γ WT or hGRK4γ 142V were prepared for immunoblotting. Histone deacetylase (HDAC) activity was fluorometrically measured.
Human AT 1 R Gene (AGTR1) Promoter Analysis
Human AGTR1 promoter DNA fragment from −1941 to +281 relative to the transcription start site was cloned into pGL3 luciferase reporter vector and cotransfected with pcDNA, hGRK4γ WT , hGRK4γ
142V
, or hGRK2 and a constant amount of plasmid harboring Renilla luciferase into hRPTCs. The cells were incubated for 24 hours followed by luciferase assay.
Generation of hGRK4γ
WT and hGRK4γ
142V

Transgenic Mice
We generated hGRK4γ WT and hGRK4γ 142V transgenic mice to determine causality between GRK4 variants and BP.
1 GRK4γ was chosen for this study because it regulates a limited number of G-proteincoupled receptors, 4 including the D 1 R and D 3 R which are important regulators of BP. 
Acute Renal-Specific Downregulation of Hdac1 or Hdac2
Renal Hdac1 was silenced through a renal subcapsular infusion of Hdac1-specific siRNA via an osmotic minipump. 22 The osmotic minipumps (100 µL; flow rate: 0.5 µL/h for 7 days) were filled with prevalidated Hdac1-or Hdac2-specific siRNA (delivery rate of 3 μg/d) or nonsilencing siRNA as control. The siRNAs were dissolved in an in vivo transfection reagent under sterile conditions.
BP Measurement in Transgenic Mice
BP of mice fed a normal (0.9% NaCl) or high (6% NaCl) salt diet was measured directly from the aorta via the femoral artery under pentobarbital anesthesia, or by telemetry via the carotid artery in conscious, undisturbed mice starting at 7 days after the surgical implantation of the transmitters.
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Ang II and Candesartan Treatment
The mice were anesthetized with isoflurane for the subcutaneous implantation of osmotic minipumps to administer Ang II (1 μg/kg per mimute at the rate of 1 μL/h) or candesartan (0.139 μg/kg per minute at the rate of 0.5 μL/h for 4 days). BP was measured in anesthetized 1 and conscious mice.
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Reverse Transcription Polymerase Chain Reaction and Real-Time Quantitative Polymerase Chain Reaction
The transgene copy number was calculated using the absolute quantitative method.
Immunoblotting
Renal sodium transporters, pump, and channels: kidneys were prepared for immunoblotting using rabbit polyclonal antibodies against NHE3, NaPi2, NKCC2, NCC, ENaC subunits (gifts from Dr Mark A. Knepper, Epithelial Systems Biology Laboratory, National Heart, Lung, and Blood Institute, and National Institutes of Health), actin (housekeeping protein), and mouse monoclonal antibody against Na 
Generation of Anti-GRK4 Antibody
Rabbit antimouse GRK4 (peptide sequence: KDLNENEDDLSSLEKYK) antibody was generated. The specificity of the antibody was validated by Western blot.
Urine Sodium and Creatinine Assays
Mouse urine samples were collected in metabolic cages for 24 hours under basal conditions. The urine sodium was determined using the Beckman Synchron EL-ISE electrolytes system and creatinine was measured by using QuantiChrom Creatinine Assay Kit. 
Study Approval
All animals used in this study were bred and maintained at the animal facility at Georgetown University and University of Maryland School of Medicine. The studies were conducted in accordance with National Institutes of Health guidelines for the care and the use of laboratory animals in research, and approved by Georgetown University and the University of Maryland School of Medicine Institutional Animal Care and Use Committees (IACUC).
Statistics
The data are expressed as mean±SEM. Significant differences between and among groups were determined by 1-way ANOVA and Scheffe or Holm-Sidak test for groups >2 or Student's t test for groups=2. P<0.05 was considered significant.
Results
hGRK4γ
142V is More Abundant Than the Wild-Type Isoform in the Nucleus
We initially determined the renal expression profiles of AT 1 R in hGRK4γ 142V transgenic mice and those expressing the wild-type human GRK4 (hGRK4γ WT ). The renal AT 1 R transcript and protein levels were greater in male and female GRK4γ 142V than in GRK4γ WT transgenic mice ( Figure 1A ), suggesting a regulatory role for hGRK4γ 142V on AT 1 R expression. To elucidate the mechanism for the upregulation of AT 1 R, we determined the subcellular localization of heterologous hGRK4γ
142V and hGRK4γ WT in HEK-293 cells, which have functional endogenous AT 1 R but minimal GRK4 expression. Both forms of GRK4 were distributed in the plasma membrane, cytosol, and the nucleus ( Figure 1B ), similar to the distribution of endogenous GRK4 in hRPTCs 1 ( Figure 1B ). We confirmed the nuclear localization of GRK4γ by immunoblotting nuclear and cytoplasmic fractions and found that the nuclear/cytoplasmic ratio of hGRK4γ was significantly higher in cells expressing hGRK4γ 142V than for hGRK4γ WT ( Figure 1C ), similar to the distribution of endogenous GRK4 in several hRPTC lines ( Figure 1D ). GRK4 contains a putative nuclear localization signal. 23 GRK5, which has a well-characterized nuclear localization signal, 24, 25 negatively modifies the transcription of several Gα q -regulated genes and acts as a kinase for HDAC5. 25, 26 HDACs remove acetyl groups from lysine residues of histones, allowing the histones to bind tightly with DNA, preventing transcription. However, activation via serine phosphorylation of class II HDACs results in HDAC transport into the cytoplasm, 25 preventing action on the nuclear histones, leading to a relaxed conformation of the nucleosome, allowing gene expression to occur.
hGRK4γ
142V Promotes HDAC1 Egress From the Nucleus and Upregulates AT 1 R Expression
The importance of HDACs in hypertension has been reported and their effects may be organ-specific. In the kidney, the inhibition of total HDAC activity increases the transcription of renin-angiotensin-aldosterone system genes, including Agtr1, whereas Ang II increases HDAC1 expression. 27 In extrarenal tissues, systemic HDAC inhibition decreases the hypertensive response by decreasing AT 1 R expression in the heart of spontaneously hypertensive rats, 28 whereas the class III HDAC sirtuin 1 downregulates AT 1 R expression and Ang II activates HDAC5 in vascular smooth muscle cells. 29, 30 We found in hRPTCs that endogenous GRK4 coimmunoprecipitated with endogenous HDAC1 (Figure 2A ). The expression of hGRK4 142V in hRPTCs increased HDAC1 phosphorylation ( Figure 2B ), decreased nuclear HDAC1 activity ( Figure 2C ), and increased AT 1 R expression ( Figure 2D ), relative to those in cells expressing hGRK4 WT . Thus, hGRK4
142V promotes HDAC1 activation and nuclear export to the cytoplasm, resulting in increased AT 1 R expression.
We next evaluated the effect of hGRK4γ 142V and hGRK4γ
WT on the activity of the AGTR1 promoter in hRPTCs. The AGTR1 promoter spans ≈2.2 kb from −1941 to +281 nucleotides relative to the transcriptional start site and contains most of the regulatory elements that control the expression of the AT 1 R. 31 The CpG island predictor tool (http://www.urogene.org/ methprimer) showed that the human AGTR1 promoter contains a 461-bp CpG island at −304 to +156 nucleotide position that can be acted on by the HDACs. We found that hGRK4γ
WT , but not GRK2, inhibited the activity of the AGTR1 promoter, and thus gene expression, whereas hGRK4γ 142V markedly enhanced its activity ( Figure 2E ).
Depletion of Renal HDAC1 Increases AT 1 R Expression and BP in Mice
We next infused Hdac1-specific siRNA into the kidney of C57Bl/6J mice for 7 days; the hGRK4γ 142V mice are on a C57Bl/6J genetic background. Hdac2-specific and nonsilencing siRNA were used as controls. Depletion of renal HDAC1 increased renal Agtr1 expression ( Figure 3A ) and elevated systolic BP ( Figure 3B ), which was reduced by AT 1 R blockade with candesartan ( Figure 3C ) in another set of mice. Depletion of renal HDAC2 did not alter the AT 1 R expression ( Figure 3A ) but decreased the systolic BP ( Figure 3B ). The reason for the decreased BP with renal HDAC2 depletion is unclear, although it is not due to increased renal HDAC1 because HDAC1 expression in total kidney homogenates was unchanged with HDAC2 depletion ( Figure 3D ); HDAC2 expression was not altered by renal HDAC1 depletion ( Figure 3E ).
hGRK4γ 142V Transgenic Mice Have Decreased Renal HDAC1 and Hypertension
Mice harboring the hGRK4γ 142V are viable, healthy, and indistinguishable from control mice. 1 To eliminate the confounding effects of the endogenous mouse Grk4 gene, we crossed the hGRK4γ 142V with Grk4 −/− mice and studied the mice that express the human transgene but not the endogenous mouse gene (hGRK4γ
). hGRK4γ 142V mice, with or without the endogenous Grk4 gene, had systolic and diastolic BPs that were higher than in control mice ( Figure 4A ), in agreement with previous studies. 1 We also found that Grk4 −/− mice had low basal BP, indicating that in the C57BL/6J mouse, which has increased renal GRK4 expression on high-salt intake, 21 GRK4 constrains the D 1 R function. Conscious hGRK4γ 142V mice had elevated BP throughout most of the day and were hypertensive at night when they were awake and active, in contrast to nontransgenic and hGRK4γ WT mice that had normal BP ( Figure 4B ). The increased BP of hGRK4γ 142V mice was independent of age and was not related to GRK4 transgene copy number ( Figure 4C ), renal GRK4 transgene mRNA level ( Figure 4D ), or GRK4 protein expression, that was not affected by sex ( Figure 4E ). Salt loading did not increase further the high BP of hGRK4γ 142V mice ( Figure 4F ), although it increased the BP of nontransgenic littermates, which were on a salt-sensitive C57Bl/6J genetic background. 21 The increased BP correlated with the reduction of HDAC1 in whole kidney homogenates and nuclear fractions, but not in cytosolic fractions, in hGRK4γ 142V mice compared with hGRK4γ WT mice ( Figure 4G ), corroborating the regulatory role of hGRK4γ 142V on HDAC1 expression, activation, and subcellular localization (Figures 2 and 3 ).
hGRK4γ 142V Transgenic Mice Have Lower Plasma Renin Activity
We also explored the interaction between GRK4 and the renin-angiotensin-aldosterone system by evaluating the expression and activity of renin-angiotensin-aldosterone system components. hGRK4γ 142V mice had lower plasma renin activity than hGRK4γ WT mice, although there were no differences in plasma angiotensinogen concentrations and serum angiotensin-converting enzyme activities ( Figure S1 in the online-only Data Supplement). The lower plasma renin activity is consistent with the association of hGRK4γ 142V and low plasma renin activity in a hypertensive Japanese population with GRK4 gene variants. 13 Stimulation of the mouse D 1 R, which is expressed in the juxtaglomerular cells, increases renin secretion, 32 when cyclooxygenase-2 is suppressed, 33 whereas stimulation of the AT 1 R, which is also expressed in juxtaglomerular cells, 34 downregulates renin synthesis and secretion. 35 The expression of hGRK4γ 142V impairs the D 1 R activity and heightens AT 1 R activity, which together result in reduced renin secretion. Urine aldosterone levels were not different between hGRK4γ 142V and hGRK4γ WT transgenic mice (16.06±7.42 ng/ mg creatinine versus 17.53±9.06, hGRK4γ
142V
; n=4/group).
AT 1 R Blockade or Loss Prevents the hGRK4γ
142V -
Mediated Hypertension in Mice
The acute subcutaneous infusion of Ang II increased daytime BP to a greater extent in conscious hGRK4γ
142V than in hGRK4γ WT mice ( Figure 5A ), conceivably because hGRK4γ 142V mice had more AT 1 R ( Figure 1A) . A chronic subcutaneous infusion of the AT 1 R blocker candesartan decreased daytime BP to a greater extent in hGRK4γ 142V than in hGRK4γ WT mice, such that their actual BPs became the same ( Figures 5B and  5C ), indicating an unfettered AT 1 R activity in hGRK4γ 142V mice and tonic AT 1 R activity in hGRK4γ WT mice. To corroborate the role of AT 1 R in the hypertension observed in hGRK4γ 142V mice, we crossed these mice with Agtr1a −/− mice and observed that the loss of 1 of the 2 Agtr1a alleles was sufficient to prevent the hypertensinogenic effect of hGRK4γ 142V ( Figure 5D ), regardless of sex ( Figure 5E ).
Chronic hypertension develops when a higher BP is needed to excrete the same amount of sodium as when the BP is normal, that is, there is a shift of the pressure-natriuresis curve to the right, 7 which was observed in the hypertensive hGRK4γ 142 V mice ( Figure 5F ). The shift in the pressurenatriuresis plot to the right may be because of: (1) increased renal AT 1 R expression and function (this study); (2) decreased renal dopamine receptor expression or function 1, 3, 8, 20 ; and (3) ultimately, to increased sodium transport that may be related to increased ion transporter expression, that is, NKCC2 (Figure 5G ) or activity. 
Discussion
The intricate regulation of renal sodium transport and BP is mainly governed by the combined effects of 2 contrasting systems, that is, the antihypertensinogenic (eg, peripheral dopamine system) and prohypertensinogenic systems (eg, renin-angiotensin-aldosterone and sympathetic nervous systems). This push and pull dynamic is best exemplified by the interaction between the D 1 R and AT 1 R. These receptors, along with Na + , K + -ATPase, comprise a multiprotein complex where 1 receptor antagonizes the other. 36, 37 The D 1 R possesses a region at the C-terminal tail that can directly interact with both the AT 1 R and Na + , K + -ATPase. 36 This may allow an acute, shortterm D 1 R agonism to cause the rapid partial internalization of AT 1 R and complete abrogation of AT 1 R signaling. 36 Similarly, short-term treatment with Ang II diminishes D 1 R at the plasma membrane in the Wistar Kyoto rat, but not spontaneously hypertensive rat, although chronic treatment results in increased D 1 R expression, 37 possibly as compensation. Ang II also decreases dopamine uptake and dopamine synthesis in the renal cortex. 38 Simultaneous activation of D 1 R and AT 1 R can increase or decrease Na + , K + -ATPase activity that is dependent on the intracellular sodium concentration, an increase of which favors D 1 R action. 39 The reciprocal antagonism between D 1 R and AT 1 R is also performed by exerting opposite effects on a common intracellular signaling pathway (ie, adenylyl cyclase/cAMP), and on the same targeted effector protein (eg, Na + , K + -ATPase). 37, 40 We, now, identify and demonstrate the unique role of GRK4 as a shared modulator for D 1 R and AT 1 R expression and activity in the long term ( Figure 6 ). , or nontransgenic (NT) littermates as another set of controls, on normal (0.9% NaCl) and high (6% NaCl) salt diet, n=5 to 9 per group. G, Histone deacetylase type 1 (HDAC1) expression in whole kidney homogenates and nuclear and cytosolic fractions from transgenic mice expressing hGRK4γ WT LD, Armando I, Jose PA, unpublished data), leading to the loss of natriuretic response during moderate sodium excess. 1 Second, by acting in a non-GRK fashion, it phosphorylates HDAC1, leading to increased AT 1 R expression and activity, and antinatriuresis. These result in high BP, thus highlighting the crucial role of the GRK4 variant in hypertension. Indeed, alterations in both D 1 R (diminished activity) and AT 1 R (enhanced activity) have been reported as concurrent requirements for hypertension.
19,20,41
hGRK4γ
142V increased AT 1 R in rat aorta-derived A10 vascular smooth muscle cells and aorta of hGRK4γ 142V transgenic mice, causing a greater Ang II-mediated vasoconstriction. 42 This demonstrates that the regulation of AT 1 R expression by hGRK4γ 142V extends to extrarenal tissues and may play an important contributory role in hypertension.
The apparent deleterious effect of HDAC1 inhibition by GRK4γ
142V may seem to contradict the beneficial effects of systemic HDAC inhibitors on inflammation, asthma, 43 pulmonary circulation, 44 oncogenesis, 45 kidney disease, 46 myocardial hypertrophy, 47, 48 and BP control. 28, 49 However, class 1 HDAC inhibition may have deleterious effects on cardiac function. 50 These contrasting reports could be related to the fact that the HDAC inhibitors used were HDAC class-specific and not subtype-specific. Our current studies show that renalselective downregulation of HDAC1 increased BP, whereas renal-selective downregulation of HDAC2 decreased BP. A recent review indicated the lack of information on the regulators of class I HDACs. 48 The current studies show that GRK4 selectively regulates HDAC1 but not HDAC2.
Our findings highlight the relevance of GRK4 in the pathogenesis of hypertension. The GRK4 gene is one of the few genes that fulfill the criteria 51, 52 for ascribing a gene as causal of a complex disorder, such as hypertension. These include supporting data from linkage studies in several ethnic populations, comprehensive sequence analyses, in vitro studies using pertinent cell lines, and definitive evidence involving transgenics and gene knockout models. GWAS, which have identified only ≈2% of the genetic factors believed to influence BP, 53 failed to associate the GRK4 variants with hypertension. One reason for the nonassociation may be the use of stringent correction and requirement for independent replication, resulting in higher type 2 error rates. 54 Another reason may be the failure to include epistasis and epigenetics in the analyses. 55 , 56 The importance of gene-gene interactions and epigenetic variations is supported by the association of the GRK4 variants with variants of other genes that are implicated in the pathogenesis of hypertension, [11] [12] [13] [14] and by this study that shows the effect of the GRK4 142V on HDAC1 activation, and thus on nucleosome conformation and gene expression. Moreover, some of the GWAS arrays used in various analyses do not include all of the 3 GRK4 variants, for example, Affymetrix chips do not have GRK4
142V
. Our studies illustrate the interplay between genetic and epigenetic mechanisms that promote the development of hypertension in rodents. Indeed, GRK4, by its ability to regulate several genes (eg, DRD1, DRD3, and AGTR1) involved in renal function and BP control, may be a key to understanding the apparent polygenic nature of essential hypertension.
Perspectives
The pleiotropic effects of the hGRK4γ 142V that perturb D 1 R expression/function and, at the same time, augment AT 1 R expression/function demonstrate how one gene may affect other physiologically relevant genes and hence, would have a greater influence on BP and be an attractive target, that is, pharmacogenetics. Considering that GRK4 affects at least 3 important regulators of renal sodium excretion and BP, that is, D 1 R, D 3 R, and AT 1 R, and these receptors, in turn, affect other receptors and proteins that modulate BP homeostasis, the use of GRK4 and its variants in predicting which drug combination is most effective in managing the disorder is considerable. For example, hypertensive carriers of hGRK4 142V had a greater decrease in systolic BP in response to angiotensin receptor blockers than noncarrier hypertensive patients. 57 More importantly, this will help in identifying which individuals are at a greater risk to develop hypertension so that timely preventive measures can be instituted. Early identification includes genetic testing for individuals who are prehypertensive and the screening of unaffected family members of hypertensive patients. Indeed, our data can easily translate into clinical medicine by providing a framework to predict clinical phenotype, effective drug response, and individualize therapy.
Generation of hGRK4 142V
/Agtr1a
+/-and GRK4
142V
/Agtr1a -/-mice
The role of the AT 1 R gene (Agtr1a) in the hypertension of GRK4 142V mice (>98% C57BL/6 background) was studied by cross-breeding with Agtr1a 
Acute renal-specific down-regulation of Hdac1or Hdac2
Renal Hdac1 was silenced through a renal subcapsular infusion of Hdac1-specific siRNA via an osmotic minipump, which allows renal-selective silencing of any gene of interest (22) . Adult male C57BL/6J mice were uninephrectomized 1 week prior to the implantation of the minipump under pentobarbital anesthesia (50 mg/kg body weight, intraperitoneally). The osmotic minipumps (100 µl; flow rate: 0.5 µl/hr for 7 days) were filled with pre-validated Hdac1-or Hdac2-specific siRNA (delivery rate of 3μg/day) or non-silencing siRNA as control. The siRNAs were dissolved in an in vivo transfection reagent (TransIT® In Vivo Gene Delivery System, Mirus) under sterile conditions. The minipumps were fitted with a polyethylene delivery tubing (Alzet #0007701) and the tip of the tubing was inserted within the subcapsular space of the remaining kidney. Surgical glue was applied at the puncture site to hold the tubing in place and prevent extra-renal leakage. The osmotic pump was sutured to the abdominal wall to prevent excessive movement of the pump for the duration of the study. Tissues were harvested after the last blood pressure determination.
Blood pressure measurement in transgenic mice
Blood pressure of hGRK4γ WT or hGRK4γ 142V transgenic mice, or non-transgenic littermates fed a normal (0.9% NaCl) or high (6% NaCl) salt diet was measured directly from the aorta via the femoral artery under anesthesia, or by telemetry via the carotid artery in conscious, undisturbed mice starting at 7 days after the surgical implantation of the transmitters (21) .
Angiotensin II and candesartan treatment
The mice were anesthetized with isoflurane for the subcutaneous implantation of osmotic minipumps to administer angiotensin II (1 g/kg/min at the rate of 1 μl/hr) or candesartan (0.139 g/kg/min at the rate of 0.5 μl/hr/4 days). Blood pressure was measured in anesthetized (1) and conscious mice (21) .
RT-PCR and real-time qPCR
The transgene copy number was calculated using the absolute quantitative method (Charles River Laboratories). Genomic DNA was extracted from the mouse tail. The human transgene specific primer sequences were as follows: forward primer 5'TGAAGCAGCACCCCGTG3', reverse primer 5'GGCTCCAGCATGTTTGCC3'. The probe (5'CCAGCCTCCTGAAGTTGATGTCCTTGA3') was labeled with fluorophore-VIC at 5' and TAMRA quencher at 3'. The PCR amplification and detection used the ABI Prism 7700 Sequence Detection System (Applied Biosystems). Transgene copy number was calculated by using non-transgenic mouse DNA as a negative control and GRK4 cDNA as the standard gene copy number. The transgene copy numbers were calculated using the absolute quantitative method (Charles River Laboratories).
Mouse kidney RNA extracted by TRIzol (Invitrogen) was dissolved in diethylpyrocarbonatetreated water and treated with DNase I (Roche). The DNA-free RNA was subjected to first-stand cDNA synthesis by applying SuperScript II reverse transcriptase (Invitrogen) and random hexamer primers (Promega). These yielded PCR products of 530 and 528 base pairs for the human transgene and β-actin, respectively. The PCR products were resolved in 1.5% agarose gel in TBE buffer. The band density of human transgene product was normalized to the band density of β-actin. Linearity of both reactions over the range studied in these experiments was experimentally confirmed; PCR also confirmed the absence of genomic DNA contamination.
The mouse Agtr1a-specific primer sequences were as follows: forward 5'CACCTATGTAAGATCGCTTCG3', reverse 5'GGATGACGGCTGGCAAACTG3'. β-actin was used as housekeeping gene and amplified by forward primer (5'AGAGGGAAATCGTGCGTGAC3'), reverse primer (5'CAATAGTGATGACCTGGCCGT3'). Quantification was performed using the Applied Biosystems 7700 Sequence Detector with the SYBR Green PCR Master Mix Reagents Kit (Applied Biosystems Inc.). The ∆∆Ct method was used to calculate cDNA content with wildtype transgenic mice as calibrator.
Immunoblotting
Renal sodium transporters, pump, and channels: The kidneys were homogenized and plasma membrane-enriched fractions were obtained by centrifugation of homogenates in 250 mM sucrose, 10 mM triethanolamine, and protease inhibitors at 17,000 x g for 30 min at 4 o C. The proteins (10-40 g), separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes (Bio-Rad), were probed with the indicated primary antibodies and then exposed to horseradish peroxidase-conjugated secondary antibodies (Pierce). The primary antibodies were rabbit polyclonal antibodies against NHE3, NaPi2, NKCC2, NCC, ENaC subunits (gifts from Dr. Mark A. Knepper, LKEM, NHLBI, NIH), actin (Sigma) and mouse monoclonal antibody against Na + , K + -ATPase  subunit (Upstate Biotechnology). The chemiluminescent signals were quantified by the NIH Image J program and normalized against the corresponding actin bands.
Renal AT 1 R: Mouse kidney proteins were probed with antibodies against AT 1 R (SCBT, sc-1173) and β-actin (Sigma, A1978) and GRK4. GRK4 has four isoforms in humans, i.e., α, β, γ, and δ (4,9). We chose to study GRK4γ because in contrast to GRK4α, GRK4γ regulates only a few GPCRs (4), including the D 1 R (1,3) .
Generation of anti-GRK4 antibody
Rabbit anti-mouse GRK4 (peptide sequence: KDLNENEDDLSSLEKYK) antibody was generated (Abgent). The specificity of the antibody was validated by western blot.
Urine sodium and creatinine assays
Mouse urine samples were collected in metabolic cages for 24 hr under basal conditions. The urine sodium was determined using the Beckman Synchron EL-ISE electrolytes system and creatinine was measured by using QuantiChrom TM Creatinine Assay Kit (BioAssay Systems), according to the manufacturer's protocol.
Angiotensinogen, ACE, and renin assays
Plasma total angiotensinogen was measured using an EIA kit (Immunobiological Laboratories Co, Ltd, Japan). Serum ACE activity was also measured with a commercially available kit (ALPCO). Briefly, ACE acts on the synthetic substrate tritiated hippuryl-glyclyglycine to produce tritiated hippuric acid. After acidification to stop the reaction, the tritiated substrate was removed from the unreacted substrate by extraction with scintillation fluid and counted in a -scintillation counter. Plasma (treated with EDTA and PMSF) renin activity was measured as the rate of angiotensin I generation in the presence of excess exogenous substrate. Angiotensin I was quantified by RIA using a clinical human renin kit (DiaSorin). All assays were performed by the Hypertension Core Laboratory, Wake Forest University School of Medicine.
Study approval
All animals used in this study were bred and maintained at the animal facilities at Georgetown University and University of Maryland School of Medicine. The studies were conducted in accordance with NIH guidelines for the care and use of laboratory animals in research, and approved by Georgetown University and the University of Maryland School of Medicine Institutional Animal Care and Use Committees (IACUC).
